Clinical Trials Logo

Pollution; Exposure clinical trials

View clinical trials related to Pollution; Exposure.

Filter by:

NCT ID: NCT04541498 Completed - Clinical trials for Cardiovascular Diseases

Impact of Air Pollution and Climate Changes on the Epidemiology of Cardiovascular Disease

PL-PARTICLES
Start date: January 1, 2019
Phase:
Study type: Observational

Despite the fact that the topic of air pollution has been in focus of researchers for many years, there are no big studies that take up the matter of its influence on acute coronary, cerebral syndromes and CVD mortality in Europe. Taking into consideration the scarce number of surveys from Europe the investigators decided to analyze the impact of air pollution on cardiovascular diseases and CVD mortality in Poland.

NCT ID: NCT04464720 Completed - Asthma in Children Clinical Trials

AIM to Improve Asthma: Airflow Improvements During Meal-Prep

AIM
Start date: May 24, 2021
Phase: N/A
Study type: Interventional

The investigators propose a pilot trial of kitchen ventilation in the homes of children using a youth engaged research strategy.

NCT ID: NCT04353232 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Impact of Lifetime Exposure to Air and Noise Pollution on Cardiovascular Disease and Mortality - the AIRCARD Study.

AIRCARD
Start date: January 2, 2020
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to determine the impact of individually lifetime accumulated exposure to air and noise pollution on the incidence and prevalence of cardiovascular diseases (CVD) and mortality. Air as well as noise pollution have harmful effects on human health. Experimental and clinical studies have shown a strong impact between particulate matter (PM2.5) and cardiovascular disease (CVD). Prolonged exposure to PM2.5 has been associated with the development of atherosclerosis and adverse cardiovascular events. However, also short-term exposure has been linked to acute coronary events. PM2.5 is, however, a combination of many components of specific pollutants that have a size of two and a half microns or less in width. However, there is a knowledge gap, as investigation into which specific components of air pollutants that contribute the most to the development of CVD is lacking. There is a need to adopt and encourage preventive measures but also put in place environmental policies that are effective in promoting the reduction of exposure to pollutants. We want to aid in this shift by showing which specific pollutants contribute the most to the development of CVD so that we can better target these specific air pollutants for better prevention initiatives.

NCT ID: NCT04068389 Completed - Pollution; Exposure Clinical Trials

Ultrafine Particles and Fetal Contamination

FOETOPUF
Start date: December 22, 2009
Phase:
Study type: Observational

The objective of this study is to evaluate the transplacental passage of fine and ultrafine particles (nanoparticles) inhaled by the mother.

NCT ID: NCT04013256 Suspended - Pollution; Exposure Clinical Trials

Controlled Exposure of Healthy Nonsmokers to Secondhand and Thirdhand Cigarette Smoke

THS04
Start date: January 20, 2020
Phase: N/A
Study type: Interventional

This study compares the health effects of dermal and inhalational exposure to thirdhand cigarette smoke to those of inhalational exposure to secondhand cigarette smoke in healthy, adult nonsmokers. Our hypothesis is that dermal exposure increases exposure to the tobacco specific carcinogen, NNK and may affect both endothelial function and epidermal integrity.

NCT ID: NCT03984188 Completed - COPD Clinical Trials

Effectiveness of Low-Dose Theophylline for the Management of Biomass-Associated COPD

Start date: February 23, 2021
Phase: Phase 3
Study type: Interventional

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, and over 90% of COPD-related deaths occurring in low- and middle-income countries (LMICs). Household air pollution (HAP) - from burning solid fuels such as wood, dung, agricultural crop waste, and coal for energy - is the primary risk factor for COPD in these settings. Biomass-related COPD has a distinct histopathology, phenotype and inflammatory profile when compared to tobacco mediated COPD. Despite the high global burden of biomass-related disease, little is known about the effectiveness of pharmacotherapies for biomass-related COPD; to date, no clinical trials have focused specifically on treatment of biomass-related COPD. This study proposes to assess the health impact of biomass-related COPD and test the effectiveness of low dose theophylline compared to standard therapy among adults with biomass-related COPD in Uganda with the aim to assess whether low-dose theophylline improves respiratory symptoms, decreases the inflammatory profile of serum biomarkers and whether administration attenuates the effect of HAP on lung function. The study additionally aims to assess whether low-dose theophylline is a cost-effective intervention based on the incremental cost-effectiveness ratio and a range of willingness to pay thresholds.

NCT ID: NCT03969459 Completed - Microbiota Clinical Trials

Impact of Exposure to Persistent Organic Pollutants During Pregnancy on the Composition of Breast Milk and Consequences on the Newborn

PESTIMICOBLAIT
Start date: May 28, 2019
Phase:
Study type: Observational

Epidemiological studies link early exposure to persistent organic pollutants (POPs) with health consequences in the newborn. Experimental studies have shown the impact of POPs on the gut microbiota. This project aims to characterize the POPs content in breast milk in an exposed population and to evaluate the impact on breast milk composition and intestinal microbiota establishment in the newborn. The health consequences will be evaluated by the clinical follow-up of the newborn.

NCT ID: NCT03904875 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Air Pollution and COPD Exacerbation

BePoPi
Start date: January 1, 2020
Phase:
Study type: Observational

There is an excess of hospitalization rates for acute exacerbation of COPD in Picardy compared to the national data. A first study realized in Picardy has shown a link between air quality and COPD. Nevertheless, the particles type is unknown and according to it, impact on COPD could be different. The investigator goal is to find a correlation between acute exacerbation of COPD consultation rate and daily ultra thin particles in Haut de France. The investigators will correlate the particles composition with daily acute exacerbation of COPD rate. All COPD patients with a diagnosis of acute exacerbation in emergency room in University Hospital of Amiens-Picardie and Lille, and Clinique de l'Europe between 01/01/2020 and 31/12/2020 will be included. For each patient, home and work address will be collected. The duration of 1 year was chosen to take into account seasonal variations. In parallel, a daily report of the rate of ozone, particles (PM2.5 and PM10), dioxide nitrogen but also odours and pollens will be done by ATMO Haut de France.

NCT ID: NCT03894995 Completed - Pollution; Exposure Clinical Trials

Optimizing Ventilation to Improve Health

Start date: June 19, 2018
Phase: N/A
Study type: Interventional

Our overall goal is to optimize preferred, ventilating windows/apertures/vents in low-income neighborhoods of Dhaka, Bangladesh. We will: I. Collect baseline data on housing types and finalize windows/vents protoypes. II. Measure the impact of improved ventilation on air exchange rates in houses in low-income neighborhoods of Dhaka and characterize the current and potential market for windows/vents in households in low-income neighborhoods of Dhaka, Bangladesh. III. Understand recipients' (tenants and landords) perceived benefits of installed window/vent designs and difficulties faced with adoption of each design

NCT ID: NCT03776773 Completed - Allergic Rhinitis Clinical Trials

Impact of Pollution on Allergic Rhinitis and Sleep Quality: the POLLAR Study

POLLAR
Start date: April 8, 2019
Phase: N/A
Study type: Interventional

It has been demonstrated that allergic rhinitis (AR) reduces sleep quality by some components such as nasal obstruction. Pollution and allergen exposure worsening AR, sleep quality is deteriorated. Sleep is associated to physical and mental health, alterations in sleep could explain the link between AR and work productivity diminution, impairment in daily activities or emotional problems. However, interactions between air pollution, sleep and allergic diseases are insufficiently understood. The main objective of this study is to determine the impact of pollution and pollens on sleep parameters.